Effects of metrizamide, a new nonionic contrast medium, on cardiac function during coronary angiography in the dog

Radiology
G TrägårdhT Vinciguerra

Abstract

Metrizamide is a new non-ionic radiopaque agent with low osmolarity and low intravenous toxicity. Hyperosmolarity is one of the factors involved in the decrease of myocardial contracility, alterations of aortic pressure, and disturbances in the cardiac rhythm which contrast media induce during coronary angiography. Metrizamide has been compared to other commonly used contrast media and was shown to produce fewer changes on the cardiac functions recorded.

Citations

Jan 1, 1979·Pharmacology & Therapeutics. Part B: General & Systematic Pharmacology·G MannesmannB Maass
May 1, 1994·European Journal of Radiology·G Rosati
Mar 1, 1981·The American Journal of Cardiology·H YamazakiR H Helfant
Sep 1, 1985·American Heart Journal·J A WisneskiD L Morris
Feb 1, 1985·Journal of the American College of Cardiology·E W GertzC Hu
Jan 1, 1984·Acta Radiologica: Diagnosis·O S OrjavikE Andrew
Jan 1, 1983·Acta Radiologica: Diagnosis·K Selin, L Björk
Jan 1, 1983·Acta Radiologica: Diagnosis·B Trägårdh, P R Lynch
Mar 1, 1981·The British Journal of Radiology·D C Cumberland

❮ Previous
Next ❯

Related Concepts

Related Feeds

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.